-

BioIntelliSense Partners with Hicuity Health to Offer Scalable End-to-End Continuous Patient Monitoring for U.S. Health Systems

The new partnership integrates the BioIntelliSense medical-grade BioButton® wearable and BioDashboard™ clinical intelligence solution with Hicuity Health’s robust patient monitoring services to scale virtual care programs from in-hospital to home

DENVER & ST. LOUIS--(BUSINESS WIRE)--BioIntelliSense, a leader in continuous health monitoring and clinical intelligence, and Hicuity Health, a leading provider of tech-enabled virtual care services, today announced a strategic partnership to offer fully managed, end-to-end continuous patient monitoring to hospitals and health systems. This partnership addresses critical infrastructure and staffing challenges faced by hospitals and health systems, empowering them to deploy proven, scalable monitoring solutions for in-hospital care, hospital-at-home programs, post-hospital discharge and chronic remote care management.

Through this partnership, the BioIntelliSense FDA-cleared BioButton® multi-parameter device and BioDashboard™ clinical intelligence system will integrate seamlessly with Hicuity Health’s 24/7 virtual patient monitoring services, to provide nurses and other clinicians with actionable health insights and workflow efficiencies. Hicuity Health services are designed to reduce the workforce burden of on-site clinical teams and leverage decades of experience and leadership in high-acuity patient monitoring, delivering over 11 million hours annually of patient monitoring across its nationwide client base.

“The BioIntelliSense award-winning medical-grade solution, combined with Hicuity Health’s extensive experience in patient monitoring services, ensures that health systems of all sizes can now deploy and scale continuous care programs from in-hospital to home,” said James Mault, MD, CEO and Founder of BioIntelliSense. “This partnership addresses current staffing challenges for health systems by offering a comprehensive tech-enabled solution for scalable continuous care that is proven to enable earlier interventions, better patient outcomes, and more efficient use of clinical resources.”

The addition of the Hicuity Health patient monitoring service is an ideal option for hospitals and health systems looking to either initiate or expand their virtual care programs. The rechargeable, wireless BioButton® wearable continuously and passively monitors patient vital signs and biometrics, automating the collection of 1,440 measurements per patient per day. The BioDashboard clinical intelligence engine provides algorithmic-based analytics and vital sign trends which are then securely monitored by Hicuity Health. Hicuity Health’s clinical teams follow predefined workflows and escalation protocols in collaboration with the health system to support timely interventions and better patient outcomes.

“At Hicuity Health, we are committed to transforming the way healthcare is delivered through trusted and innovative virtual care solutions that scale to the needs of hospital systems nationwide,” said Lou Silverman, CEO of Hicuity Health. “By partnering with BioIntelliSense, we’re bringing an unparalleled level of support, flexibility and scalability to hospitals and health systems, helping them provide the highest level of care for patients in-hospital and at-home.”

Follow BioIntelliSense on LinkedIn for the latest news and information.

About BioIntelliSense

BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for virtual care and remote patient monitoring (RPM) from in-hospital to home. Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multiparameter vital signs and physiological biometrics through an effortless user experience. The FDA-cleared BioButton® multiparameter wearables, BioHub® gateways, BioMobile™ downloadable applications, BioCloud™ data services and the BioDashboard™ clinical intelligence system create a comprehensive tech-enhanced solution that makes continuous monitoring reliable and scalable. Through the platform’s AI-driven analytics, clinicians have access to high-resolution patient trending and data-driven insights to deliver better, safer care from in-hospital to home. Learn more at www.BioIntelliSense.com

About Hicuity Health

Hicuity Health has pioneered provider-to-provider telemedicine innovations. Serving a diverse range of clients and care venues – including health systems, hospitals, and post-acute care facilities – with its expanding line of services that includes virtual nursing, tele-ICU, remote inpatient telemetry, virtual sitter, smart device monitoring, and shared services, the company is the leader in delivering expert care on a 24 x 7 x 365 basis to high-acuity patients in high-acuity environments. The company's innovation is highlighted by its proprietary HUB workflow management technology platform, which enables seamless care delivery and informs patient management across the US serving health systems located in 35 states nationwide. Hicuity Health services offer enhanced patient outcomes, tangible ROI, and expert clinical support for bedside teams. For more information, visit www.HicuityHealth.com.

Contacts

Media Contacts:

BioIntelliSense
Eric Schudiske
Eric@s2spr.com

Hicuity Health
Ellen McEvoy
Ellen.McEvoy@hicuityhealth.com

BioIntelliSense


Release Versions

Contacts

Media Contacts:

BioIntelliSense
Eric Schudiske
Eric@s2spr.com

Hicuity Health
Ellen McEvoy
Ellen.McEvoy@hicuityhealth.com

Social Media Profiles
More News From BioIntelliSense

BioIntelliSense Announces Observational Study in Journal of Clinical Medicine Demonstrating Early Detection of Patient Deterioration with FDA-cleared BioButton® Continuous Monitoring Wearable Device

DENVER--(BUSINESS WIRE)--BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced publication of peer-reviewed research in the Journal of Clinical Medicine titled, “A Retrospective Observational Study of Continuous Wireless Vital Sign Monitoring via a Medical Grade Wearable Device on Hospitalized Floor Patients.” This study, which was conducted over 15 months in the medical-surgical units of two U.S. hospitals, highlights the transformative potential of...

BioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™ System for Continuous Patient Monitoring

DENVER--(BUSINESS WIRE)--BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces FDA clearance of the rechargeable BioButton® Multi-Patient wearable and BioDashboard™ system to cost-effectively grow and scale hospital virtual care programs. The BioButton Multi-Patient medical device expands the BioIntelliSense award-winning portfolio of continuous patient monitoring solutions by offering a rechargeable and reusable inpatient solution for automating vital sig...

BioIntelliSense Announces Completion of Houston Methodist Inpatient Expansion of the BioButton® Continuous Patient Monitoring Solution

DENVER & HOUSTON--(BUSINESS WIRE)--BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces completion of Houston Methodist’s inpatient expansion of the BioButton® continuous patient monitoring solution across all 2,653 non-ICU beds at the system’s eight hospitals. The FDA-cleared BioIntelliSense BioButton multiparameter wearable is applied to patients at the time of admission with centralized command center monitoring by Houston Methodist’s multi-disciplinar...
Back to Newsroom